These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34376634)

  • 1. Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study.
    Yuan X; Wang Y; Li X; Jiang J; Kang Y; Pang L; Zhang P; Li A; Lv L; Andreassen OA; Fan X; Hu S; Song X
    Transl Psychiatry; 2021 Aug; 11(1):422. PubMed ID: 34376634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut mycobiota dysbiosis in drug-naïve, first-episode schizophrenia.
    Yuan X; Li X; Kang Y; Pang L; Hei G; Zhang X; Wang S; Zhao X; Zhang S; Tao Q; Zhang L; Zhu Q; Lv L; Fan X; Hu S; Song X
    Schizophr Res; 2022 Dec; 250():76-86. PubMed ID: 36370535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 16S rRNA gene sequencing reveals altered gut microbiota in young adults with schizophrenia and prominent negative symptoms.
    Chen YH; Yu H; Xue F; Bai J; Guo L; Peng ZW
    Brain Behav; 2024 Jun; 14(6):e3579. PubMed ID: 38841824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gut microbiome profile in patients with schizophrenia and healthy controls - A plausible non-invasive biomarker?
    Gokulakrishnan K; Nikhil J; Viswanath B; Thirumoorthy C; Narasimhan S; Devarajan B; Joseph E; David AKD; Sharma S; Vasudevan K; Sreeraj VS; Holla B; Shivakumar V; Debnath M; Venkatasubramanian G; Varambally S
    J Psychiatr Res; 2023 Jun; 162():140-149. PubMed ID: 37156128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low-frequency rTMS combined with risperidone on the gut microbiome in hospitalized patients with chronic schizophrenia.
    Li R; Fu R; Cui ZQ; Guo L; Chen YH; Bai J; Yang JB; Tan QR; Peng ZW
    Brain Res; 2023 Nov; 1819():148539. PubMed ID: 37598899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbial signatures and differences in bipolar disorder and schizophrenia of emerging adulthood.
    Chen YH; Zhou CH; Yu H; Wu WJ; Wang YW; Liu L; Hu GT; Li BJ; Peng ZW; Wang HN
    CNS Neurosci Ther; 2023 Jun; 29 Suppl 1(Suppl 1):5-17. PubMed ID: 36468448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia.
    Yuan X; Zhang P; Wang Y; Liu Y; Li X; Kumar BU; Hei G; Lv L; Huang XF; Fan X; Song X
    Schizophr Res; 2018 Nov; 201():299-306. PubMed ID: 29859859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the gut microbiome in first-episode drug-naïve and chronic medicated schizophrenia correlate with regional brain volumes.
    Ma X; Asif H; Dai L; He Y; Zheng W; Wang D; Ren H; Tang J; Li C; Jin K; Li Z; Chen X
    J Psychiatr Res; 2020 Apr; 123():136-144. PubMed ID: 32065949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of interaction between polygenic risk score and intestinal fungal microbiota on the risk of schizophrenia].
    Yuan XX; Sun Y; Pang LJ; Li X; Hei GR; Zhang XY; Li JJ; Song XQ
    Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(30):2324-2329. PubMed ID: 37574830
    [No Abstract]   [Full Text] [Related]  

  • 10. [Variations in fecal microbiota of first episode schizophrenia associated with clinical assessment and serum metabolomics].
    Wang XP; Zhang YY; Lu TL; Lu Z; Kang ZW; Sun YY; Yue WH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):863-873. PubMed ID: 36241229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of risperidone on serum homocysteine levels in first-episode, drug-naïve patients with schizophrenia.
    Fan N; Tan Y; Yang F; Tian L; Chen S; Li J; Wang Z; Zhang X
    Neurosci Lett; 2017 May; 650():168-173. PubMed ID: 28419824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia].
    Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia.
    Flowers SA; Baxter NT; Ward KM; Kraal AZ; McInnis MG; Schmidt TM; Ellingrod VL
    Pharmacotherapy; 2019 Feb; 39(2):161-170. PubMed ID: 30620405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment.
    Li M; Chen Z; Deng W; He Z; Wang Q; Jiang L; Ma X; Wang Y; Chua SE; Cheung C; McAlonan GM; Sham PC; Collier DA; Gong Q; Li T
    Psychol Med; 2012 Jul; 42(7):1475-83. PubMed ID: 22030695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia.
    Li Z; Hu M; Zong X; He Y; Wang D; Dai L; Dong M; Zhou J; Cao H; Lv L; Chen X; Tang J
    Sci Rep; 2015 Dec; 5():18553. PubMed ID: 26680692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    Neuropsychopharmacology; 2005 Aug; 30(8):1532-8. PubMed ID: 15886721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylaspartate reduction in the medial prefrontal cortex following 8 weeks of risperidone treatment in first-episode drug-naïve schizophrenia patients.
    Zong X; Hu M; Li Z; Cao H; He Y; Liao Y; Zhou J; Sang D; Zhao H; Tang J; Lv L; Chen X
    Sci Rep; 2015 Mar; 5():9109. PubMed ID: 25778460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shotgun metagenomics reveals abnormal short-chain fatty acid-producing bacteria and glucose and lipid metabolism of the gut microbiota in patients with schizophrenia.
    Li Z; Qing Y; Cui G; Li M; Liu T; Zeng Y; Zhou C; Hu X; Jiang J; Wang D; Gao Y; Zhang J; Cai C; Wang T; Wan C
    Schizophr Res; 2023 May; 255():59-66. PubMed ID: 36965360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the gut microbiota in type 2 diabetics with or without subclinical hypothyroidism.
    Lv Y; Liu R; Jia H; Sun X; Gong Y; Ma L; Qiu W; Wang X
    PeerJ; 2023; 11():e15193. PubMed ID: 37073275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.